Most Recent Campaign Headlines
The US EPA has chosen a time when Americans are worried about the COVID-19 pandemic to announce its approval of a potentially dangerous experiment with Oxitec's GM mosquitoes, with the claimed purpose of preventing mosquito-borne disease.
The Bayer AG annual shareholders’ meeting got underway Tuesday in Germany, drawing the attention of not only investors and analysts but also activists, lawyers and cancer patients who want to see Bayer make amends for alleged misdeeds by Monsanto, which Bayer bought two years ago.
The meeting was to be an in-person event in Bonn, Germany but due to fears about large gatherings that could spread the Covid-19 virus, Bayer instead is hosting a video webcast of the meeting.
Many people who've never stepped into a soybean or corn field are familiar with pesticides like the cancer-linked glyphosate in Roundup and drift-prone dicamba. But chances are slim that anyone outside the pesticide and farming industries has heard a whisper about isoxaflutole, which earlier this month the Environmental Protection Agency announced it had approved for use on as much as 90 million acres of genetically engineered soybeans in 25 states throughout the Midwest.
Earlier this year, our colleague Carey Gillam was offered a speaking slot by a Bayer shareholders’ group at the company’s annual meeting in Bonn, Germany. Due to Covid-19, the in-person meeting has been canceled and the Bayer shareholders convened in a virtual meeting on April 28 at 10:00 Central European Summer Time (CEST). In lieu of attending the event, of Ms. Gillam was invited to submit a video and written comments, which we have posted here.
For more reporting on the Bayer shareholder meeting and updates on litigation involving the company, see Gillam’s Monsanto Roundup and Dicamba Trial Tracker.
A record-shattering fine levied against the Grocery Manufacturers Association for concealing the identities of the food and beverage companies that spent $11 million to defeat a GMO-labeling initiative in 2013 was upheld Thursday by the Washington Supreme Court.
The pandemic that we have long been told is coming any day now has unfortunately arrived. The new strain of coronavirus, named COVID-19, has taken the world by storm, practically shutting down the global economy and overwhelming the hospital systems.
This week, the U.S. Environmental Protection Agency announced that soybean farmers in 25 states are now able to spray a pesticide that the agency has determined is likely to cause cancer and drift hundreds of feet from where it is applied.
Bayer AG is reneging on negotiated settlements with several U.S. law firms representing thousands of plaintiffs who claim exposure to Monsanto’s Roundup herbicides caused them to develop non-Hodgkin lymphoma, sources involved in the litigation said on Friday. The reversal comes as U.S. courts are closed to the public because of the spreading coronavirus, eliminating the specter of another Roundup cancer trial in the near future.
If consumers are seeking fair and balanced information about GMOs, they certainly will not find it on the new FDA/USDA/EPA website called Feed Your Mind.
The US agriculture giant Monsanto and the German chemical giant BASF were aware for years that their plan to introduce a new agricultural seed and chemical system would probably lead to damage on many US farms, internal documents seen by the Guardian show.
Scientific Studies
Get Local
